Regional
Northwest Community EMS System
The current listed document is more than 24 months old and may be outdated.
Drugs and doses25
A–C Acetaminophen, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine6
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 625–1000 mg | PO | not captured | standing | page 97 |
| Other | peds | 12.5 mg/kg | PO | not captured | standing | page 97 |
| Severe pain | adult | 1000 mg | IV | not captured | standing | page 97 |
| Severe pain | peds | 15 mg/kg | IV | not captured | standing | page 97 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 6 mg | IV | not captured | standing | page 97 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 97 |
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 97 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 97 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 98 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 98 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 98 |
| Hyperkalemia | peds | 5 mg | NEB | not captured | standing | page 98 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 98 |
| Other | adult | 300 mg | IV/IO | not captured | standing | page 98 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 98 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 98 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 324 mg | PO | not captured | standing | page 98 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 99 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 99 |
| Hypotension / shock | adult | 1 mg | IV/IO | not captured | standing | page 99 |
| Hypotension / shock | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 99 |
| Organophosphate poisoning | adult | 1 mg | IV/IO | not captured | standing | page 99 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 99 |
D–F Dextrose, Diphenhydramine, Epinephrine, Etomidate, Fentanyl5
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 12.5 g | IV | not captured | standing | pages 35, 90, 99 |
| Hypoglycemia | peds | 0.5 g/kg | IV | not captured | standing | pages 35, 90, 99 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | PO | not captured | standing | pages 14, 100 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | pages 14, 100 |
| Allergic reaction | adult | 50 mg | IV | not captured | standing | pages 14, 100 |
| Allergic reaction | adult | 50 mg | IV | not captured | standing | pages 14, 100 |
| Allergic reaction | adult | 50 mg | IM | not captured | standing | pages 14, 100 |
| Allergic reaction | adult | 50 mg | PO | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | PO | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 100 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | PO | not captured | standing | pages 14, 100 |
| Dystonic reaction | adult | 50 mg | IV | not captured | standing | page 100 |
| Other | adult | 50 mg | IV/IO | not captured | standing | pages 14, 81, 100 |
| Other | adult | 50 mg | IM | not captured | standing | pages 14, 81, 100 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IO | not captured | standing | pages 14, 81, 100 |
| Other | peds | 1 mg/kg (max 50 mg) | IM | not captured | standing | pages 14, 81, 100 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | pages 14, 81, 100 |
| Allergic reaction | peds | 0.15 mg | IM | not captured | standing | pages 14, 81, 100 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 84, 101 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 23, 100, 101 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 23, 100, 101 |
| Other | adult | 0.1 mg | IV/IO | not captured | standing | pages 14, 81, 101 |
| Other | adult | 0.5 mg | IM | not captured | standing | pages 14, 81, 100 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 14, 81, 101 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 7, 101 |
| Other | peds | 0.15 mg | IM | not captured | standing | pages 14, 81, 100 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg/kg (max 40 mg) | IV/IO | not captured | standing | pages 13, 101 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | pages 7, 75, 101 |
| Severe pain | peds | 1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | pages 7, 75, 101 |
G–L Glucagon, Hydroxocobalamin, Ipratropium, Ketamine, Lidocaine5
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 90, 102 |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 90, 102 |
| Other | adult | 1 mg | IV/IO/IM/IN | not captured | standing | pages 14, 102 |
| Other | peds | 0.5 mg | IV/IO/IM/IN | not captured | standing | pages 14, 102 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | pages 31, 102 |
| Cyanide poisoning | peds | 70 mg/kg (max 5 g) | IV | not captured | standing | pages 31, 102 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | NEB | not captured | standing | pages 14, 81 |
| Allergic reaction | peds | 0.5 mg | NEB | not captured | standing | pages 14, 81 |
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 15, 82, 83, 102 |
| Asthma / bronchospasm | peds | 0.25–0.5 mg | NEB | not captured | standing | pages 15, 82, 83, 102 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg/kg | IV | not captured | standing | pages 13, 78 |
| Other | adult | 2 mg/kg | IV | not captured | standing | pages 29, 30, 48, 88, 89, 103 |
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 13, 78 |
| Other | peds | 2 mg/kg | IV | not captured | standing | pages 29, 30, 48, 88, 89, 103 |
| Severe pain | adult | 0.3 mg/kg | IV | not captured | standing | pages 7, 75, 102, 103 |
| Severe pain | adult | 0.3 mg/kg | IM/IN | not captured | standing | pages 7, 75, 102, 103 |
| Severe pain | peds | 0.3 mg/kg | IV | not captured | standing | pages 7, 75, 102, 103 |
| Severe pain | peds | 0.3 mg/kg | IM/IN | not captured | standing | pages 7, 75, 102, 103 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IO | not captured | standing | pages 6, 74, 103 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | pages 6, 74, 103 |
M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron7
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 15, 82, 86, 103 |
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | pages 15, 82, 86, 103 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV/IO | not captured | standing | pages 15, 82, 86, 103 |
| Asthma / bronchospasm | peds | 25 mg/kg | IV | not captured | standing | pages 15, 82, 86, 103 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV/IO | not captured | standing | pages 72, 103 |
| Eclampsia / pre-eclampsia | adult | 2 g | IV | not captured | standing | pages 72, 103 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | pages 21, 86, 103 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | pages 21, 86, 103 |
| VF / pulseless VT | peds | 25 mg/kg | IV/IO | not captured | standing | pages 21, 86, 103 |
| VF / pulseless VT | peds | 25 mg/kg | IV | not captured | standing | pages 21, 86, 103 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IN | not captured | standing | pages 19, 27, 38, 57, 103 |
| Agitation | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 19, 27, 38, 57, 103 |
| Other | adult | 2 mg | IV/IN | not captured | standing | pages 29, 89, 103 |
| Other | adult | 2 mg | IV/IN | not captured | standing | pages 55, 104 |
| Other | adult | 2 mg | IV/IN | not captured | standing | pages 29, 89, 104 |
| Other | adult | 2 mg | IV/IO/IN | not captured | standing | pages 27, 36, 42, 72, 91, 104 |
| Other | adult | 5–10 mg | IM | not captured | standing | pages 27, 36, 42, 72, 91, 104 |
| Other | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 29, 89, 103 |
| Other | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 55, 104 |
| Other | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 29, 89, 104 |
| Other | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | pages 27, 36, 42, 72, 91, 104 |
| Other | peds | 0.1–0.2 mg/kg | IM | not captured | standing | pages 27, 36, 42, 72, 91, 104 |
| Procedural sedation | adult | 2 mg | IV/IN | not captured | standing | pages 19, 27, 38, 57, 103 |
| Procedural sedation | adult | 2–5 mg | IV/IN | not captured | standing | pages 20, 21, 85, 103 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 20, 21, 85, 103 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IN | not captured | standing | pages 19, 27, 38, 57, 103 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.1 mg/kg | IV/IO | not captured | standing | pages 7, 104 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 1 mg | IV/IO | not captured | standing | pages 23, 28, 29, 80, 87, 88, 104 |
| Opioid overdose | adult | 1 mg | IM/IN | not captured | standing | pages 23, 28, 29, 80, 87, 88, 104 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 23, 28, 29, 80, 87, 88, 104 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | pages 23, 28, 29, 80, 87, 88, 104 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 18 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 24, 105 |
| Other | adult | 0.4 mg | SL | not captured | standing | pages 36, 105 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 8 mcg | IV/IO | not captured | standing | pages 7, 23, 24, 43, 57, 92, 105, 112 |
| Other | peds | 0.1 mcg/kg | IV/IO | not captured | standing | pages 7, 23, 24, 43, 57, 92, 105, 112 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | pages 6, 34, 45, 49, 52, 75, 93, 106 |
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | pages 6, 75, 106 |
| Nausea / vomiting | peds | 0.15 mg/kg | ODT | not captured | standing | pages 6, 34, 45, 49, 52, 75, 93, 106 |
S–Z Sodium Bicarbonate, Verapamil2
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 50 mEq | IV | not captured | standing | pages 26, 55, 106 |
| Hyperkalemia | adult | 50 mEq | IV | not captured | standing | pages 26, 106 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | pages 23, 106 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | pages 23, 106 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | pages 29, 88, 106 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | pages 29, 88, 106 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5 mg | IV | not captured | standing | pages 20, 106 |
| SVT | adult | 5 mg | IV | not captured | standing | pages 20, 106 |
Cite this
Northwest Community EMS System, United States EMS Protocol Census. 122 dose entries, effective 2024-08-05.
https://protoquiz.com/census/agencies/northwest-community-ems-system/
The census is free and not for sale. Only public agencies are named.